Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Burgel (Paris, France), E. Polverino (Barcelona, Spain), C. Harworth (Cambridge, United Kingdom), M. Murris-Espin (Toulouse, France), K. Dimakou (Athensrcelona, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menendez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), F. Blasi (Milano, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), W. Boersma (Alkmaar, Netherlands), R. Wilson (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), J. Elborn (Belfast, United Kingdom), S. Aliberti (Milano, Italy), P. Goeminne (Leuven, Belgium). Risk factors for new P. aeruginosa isolation in bronchiectasis- data from the European Bronchiectasis Registry (EMBARC). 2163

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for death among tuberculosis cases: analysis of European surveillance data Source: Eur Respir J 2008; 31: 1256-1260 Year: 2008 Eradication of Pseudomonas aeruginosa within the baseline dataset of the German Bronchiectasis Registry PROGNOSIS Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Incidence of bronchiectasis concerning tuberculosis epidemiology and other ecological factors: A Korean National Cohort Study Source: ERJ Open Res, 6 (4) 00097-2020; 10.1183/23120541.00097-2020 Year: 2020 Risk factors of pneumocytis pneumoniae in solid tumours: A case-control study Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 New isolation of non-tuberculous mycobacteria in patients with bronchiectasis - data from the European Bronchiectasis Registry (EMBARC) Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Pseudomonas aeruginosa colonisation in patients without bronchiectasis Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Epidemiology and clinical features of nontuberculous mycobacterial lung disease in a subtropical region in Japan: Analysis with a 7-year data in two major hospitals Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Risk factors for MDR pneumonia according to the 2017 International ERS/ESICM/ESCMID/ALAT guidelines Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis Year: 2019 Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Risk factors for multidrug resistant bacteria in Hospital-Acquired Pneumonia: A three-year cohort study Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010 Late Breaking Abstract - The prevalence and burden of Pseudomonas aeruginosa among bronchiectasis patients in Europe- data from the FRIENDS cohort Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections Year: 2017 Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC) Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016 TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012 Risk factors for pulmonary tuberculosis in Croatia Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017 Year: 2018 Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients Source: Eur Respir J 2006 Oct 01;28(4):740-747 Year: 2006